You are using an unsupported browser.
Some features of this site may not function properly. For optimal user experience, please view this site in Chrome, Firefox, Safari, or Edge.
Our High Burden Developing Country, or HBDC, program launched in early 2011, and has placed thousands of GeneXpert® Systems and delivered millions of Xpert® cartridges to some of the most TB-challenged geographies in the world.
Recognizing the importance of actively enabling global access to developed world molecular diagnostics, Cepheid and its partners have made the Xpert MTB/RIF cartridge available at low margin. The company continues to partner to bring further, potentially life-saving innovations to HBDC, including remote calibration and cloud-based data consolidation initiatives, in addition to the extension of the Xpert test menu that is available to our HBDC customers at special pricing.
Through the HBDC program, Cepheid is gaining significant brand awareness in emerging markets as we further extend our commercial operations outside the United States and Europe.
Each day, nearly 4,500 people lose their lives to TB and close to 30,000 people fall ill. ZDoggMD and Dr. Persing discuss the global impact of a fast and accurate TB test that also detects drug resistance in the United States and globally.
Miss SA gets behind the @StopTB campaign with the Cepheid SA team. #ItsTime to ensure access to rapid TB diagnostic testing for all #ItsTimetoEndTB #BreaktheStigma@TamarynGreen#BreaktheStigma
An incredible story of a study in rapid HIV testing on mothers and babies in Rural Tanzania.
